{
    "clinical_study": {
        "@rank": "124492", 
        "acronym": "AIRLESS", 
        "arm_group": {
            "arm_group_label": "Apneascan TM", 
            "arm_group_type": "Other", 
            "description": "autoscoring algorithms of the Apneascan TM compared to the polysomnography"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to compare, three months after implantable\n      cardioverter-defibrillator (ICD) or cardiac resynchronization therapy-defibrillator (CRT-D),\n      the apnea-hypopnea index (AHI) obtained from conventional in-lab NPSG (AHIPSG) with similar\n      indices obtained from autoscoring algorithms of the ApneaScan\u2122, an implantable\n      impedance-based respiration sensor (AHIAS)."
        }, 
        "brief_title": "Automate Detection of Sleep Apnea by ApneascanTM", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sleep Apnea", 
            "Arrhythmias"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Arrhythmias, Cardiac", 
                "Sleep Apnea Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, multi center, phase-IV with blinded analysis and central reading of\n      polysomnography trial.\n\n      The study is performed in patients with a standard CRT-D or Implantable Cardioverter\n      Defibrillator (ICD) devices indication. A total of 160 subjects will be recruited both in\n      France and Switzerland. The study duration is 03 months for each subject."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female aged > 18 years old\n\n          -  Current ICD or CRT-D device-based guidelines indication\n\n          -  patients with optimal recommended medical therapy\n\n          -  Patient willing and able of undergoing the device implant procedure\n\n          -  Patient willing and able of undergoing the LATITUDE\u00ae Patient Management system\n             procedure\n\n          -  Patient willing and able to complete the requirements of the study including the\n             signature of the Informed Consent after full explanation of the study by the\n             investigator prior to participation.\n\n        Exclusion Criteria:\n\n          -  Obstructive lung disease as defined by a FEV1/FVC less than 70%\n\n          -  Body Mass Index >35 kg/m2\n\n          -  Cardiac surgery scheduled or strong likelihood of cardiac surgery 4 months after\n             enrollment\n\n          -  Life expectancy less than 1 year\n\n          -  Inability to complete overnight PSG as defined by the protocol\n\n          -  Patient who are or suspected to be pregnant and or plan to become pregnant\n\n          -  Patient protected by the Law, under guardianship or curators\n\n          -  Concomitant participation in an interventional biomedical research trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02045173", 
            "org_study_id": "1332"
        }, 
        "intervention": [
            {
                "arm_group_label": "Apneascan TM", 
                "description": "Autoscoring algorithms with automatical detection of sleep apnea by the Apneascan TM", 
                "intervention_name": "Apneascan TM", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Apneascan TM", 
                "description": "1 night polysomnography", 
                "intervention_name": "Polysomnography", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Sleep apnea, Arrhythmias, Heart Failure, ICD, CRT-D, Apneascan", 
        "lastchanged_date": "January 22, 2014", 
        "number_of_arms": "1", 
        "official_title": "Screening for Sleep-disordered Breathing in Routine Cardiology Practice: Validation of the Apnea + Hypopnea Detection by an Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy-defibrillator (CRT-D) With Impedance-based Respiration Sensor (ApneaScanTM)", 
        "other_outcome": {
            "measure": "Evolution night by night of AHI obtained from autoscoring algorithms of the ApneaScan\u2122 implantable impedance respiration sensor", 
            "safety_issue": "No", 
            "time_frame": "From ICD or CRT-D implantation and up to 3 months"
        }, 
        "overall_official": [
            {
                "affiliation": "Grenoble Hospital University", 
                "last_name": "Jean Louis PEPIN, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Grenoble Hospital University", 
                "last_name": "Pascal DEFAYE, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Apnea-hypopnea index obtained from polysomnography and from autoscoring algorithms of the ApneaScan\u2122 implantable impedance respiration sensor", 
            "safety_issue": "No", 
            "time_frame": "Prior the ICD or CRT-D implantation and up to 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02045173"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Malignant arrhythmogenic events detected daily by the ICD / CRT-D (AF, ES, supraventricular tachycardia, sustained and non sustained ventricular tachycardia, VF) and night by night AHI assessed by the ApneascanTM", 
                "safety_issue": "No", 
                "time_frame": "baseline and up to 3 months"
            }, 
            {
                "measure": "Weekly weight readings automatically and wirelessly sent to the LATITUDE(C)", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Up to 3 months"
            }, 
            {
                "measure": "Apnea and Hypopnea index measured 3 months after ICR or CRT-D implantation compared to the Apnea and Hypopnea index measured at baseline by the polysomnography", 
                "safety_issue": "No", 
                "time_frame": "Prior the ICD or CRT-D implantation and up to 3 months"
            }
        ], 
        "source": "University Hospital, Grenoble", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Grenoble", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}